Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pavel Berka is active.

Publication


Featured researches published by Pavel Berka.


Langmuir | 2013

Ceramides in the skin lipid membranes: length matters.

Barbora Školová; Barbora Janůšová; Jarmila Zbytovská; Gert S. Gooris; Joke A. Bouwstra; P. Slepička; Pavel Berka; Jaroslav Roh; Karel Palát; Alexandr Hrabálek; Kateřina Vávrová

Ceramides are essential constituents of the skin barrier that allow humans to live on dry land. Reduced levels of ceramides have been associated with skin diseases, e.g., atopic dermatitis. However, the structural requirements and mechanisms of action of ceramides are not fully understood. Here, we report the effects of ceramide acyl chain length on the permeabilities and biophysics of lipid membranes composed of ceramides (or free sphingosine), fatty acids, cholesterol, and cholesterol sulfate. Short-chain ceramides increased the permeability of the lipid membranes compared to a long-chain ceramide with maxima at 4-6 carbons in the acyl. By a combination of differential scanning calorimetry, Fourier transform infrared spectroscopy, X-ray diffraction, Langmuir monolayers, and atomic force microscopy, we found that the reason for this effect in short ceramides was a lower proportion of tight orthorhombic packing and phase separation of continuous short ceramide-enriched domains with shorter lamellar periodicity compared to native long ceramides. Thus, long acyl chains in ceramides are essential for the formation of tightly packed impermeable lipid lamellae. Moreover, the model skin lipid membranes are a valuable tool to study the relationships between the lipid structure and composition, lipid organization, and the membrane permeability.


International Journal of Pharmaceutics | 2013

Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen.

Petr Vrbata; Pavel Berka; Denisa Stranska; Pavel Doležal; Marie Musilova; Lucie Čižinská

Sublingual administration of active pharmaceutical substances is in principle favourable for rapid onset of drug action, ready accessibility and avoidance of first pass metabolism. This administration could prove very useful in the treatment of migraines, thus two frequently used drugs were selected for our study. Sumatriptan succinate, naproxen, and its salt as well as combinations of these were incorporated into nanofibrous membranes via the electrospinning process. DSC measurements proved that the resulted membranes contained non-crystalline drug forms. SEM imaging approved good homogeneity of diameter and shape of the membrane nanofibres. The nanofibrous membranes always showed the rapid and mutually independent release of the tested drugs. The drugs exhibited very high differences in sublingual permeation rates in vitro, but the rates of both substances were increased several times using nanofibrous membranes as the drug carrier in comparison to drug solutions. The released drugs subsequently permeated through sublingual mucosa preferentially as non-ionized moieties. The prepared nanofibrous membranes proved very flexible and mechanically resistant. With their drug load capacity of up to 40% of membrane mass, they could be very advantageous for the formulation of sublingual drug delivery systems.


Photochemistry and Photobiology | 2007

Influence of aggregation on interaction of lipophilic, water-insoluble azaphthalocyanines with DOPC vesicles.

Petr Zimcik; Miroslav Miletin; Kamil Kopecky; Zbynek Musil; Pavel Berka; Veronika Horakova; Helena Kučerová; Jarmila Zbytovská; Daniel Brault

Dioleoylphosphatidylcholine unilamellar vesicles made by extrusion technique (LUVETs) were studied as the delivery system for lipophilic water‐insoluble potential photosensitizers for photodynamic therapy (PDT). Two azaphthalocyanines (AzaPcs) with hydrophobic substituents only and two also possessing two charged amino groups were introduced into the study. All compounds are insoluble in water and form aggregates in PBS with tetrahydrofuran as cosolvent. The size of these aggregates depends on the concentration of AzaPc in solution. AzaPcs with tert‐butyl substituents were found to be incorporated into the lipid bilayer of vesicles in the monomeric form even at high concentrations. The stability of LUVETs with incorporated AzaPc was excellent for at least 4 weeks. Therefore, they are suitable for use as a delivery system for these water‐insoluble photosensitizers. Very low amount of AzaPc with n‐octyl substituents incorporated into LUVETs due to its stronger self‐aggregation. Values of binding constants determined for all AzaPcs showed inverse order than expected from their lipophilicities. However, the binding constants followed the order of the strength of aggregation forces. Aggregation of AzaPcs in water medium plays a very important role in the interaction of AzaPcs with LUVETs.


International Journal of Pharmaceutics | 2014

Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption

Petr Vrbata; Pavel Berka; Denisa Stranska; Pavel Doležal; Milan Laznicek


Thermochimica Acta | 2006

Thermotropic phase behavior of long-chain alkylammonium-alkylcarbamates

Tomáš Holas; Jarmila Zbytovská; Kateřina Vávrová; Pavel Berka; Michaela Mádlová; Jana Klimentová; Alexandr Hrabálek


Archive | 2011

CARRIER FOR OROMUCOSAL, ESPECIALLY SUBLINGUAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES

Denisa Stranska; Adela Klabanova; Pavel Dolezal; Petr Vrbata; Pavel Berka; Marie Musilova


Macroheterocycles | 2011

Synthesis and Properties of Azaphthalocyanines with 1,2,3,4-Tetrahydropyrazino(2,3-b)pyrazine Moiety

Kamil Kopecky; Veronika Novakova; Miroslav Miletin; L. Plistilova; Pavel Berka; Petr Zimcik


Archive | 2014

Electrospun nanofibers comprising pharmaceutically active agents

Denisa Stranska; Pavel Dolezal; Pavel Berka; Petr Vrbata; Jan Honegr; Marie Musilova


Archive | 2017

Oromucosal nanofiber carriers for therapeutic treatment

Denisa Stranska; Jana Svobodova; Pavel Berka; Pavel Doležal


Archive | 2013

Nanofibres électrofilées comprenant des agents pharmaceutiquement actifs

Denisa Stranska; Pavel Dolezal; Pavel Berka; Petr Vrbata; Jan Honegr; Marie Musilova

Collaboration


Dive into the Pavel Berka's collaboration.

Top Co-Authors

Avatar

Denisa Stranska

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Petr Vrbata

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Marie Musilova

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Pavel Dolezal

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jarmila Zbytovská

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Pavel Doležal

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Adela Klabanova

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Alexandr Hrabálek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Kamil Kopecky

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Kateřina Vávrová

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge